| APX005M in Patients With Recurrent Ovarian Cancer (NCT05201001) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2023-09-07 |
| Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE) (NCT05142150) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2023-01-12 |
| Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype (NCT05574673) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2022-12-01 |
| Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer (NCT04742075) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2021-12-15 |
| Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer (NCT03806049) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2019-12-01 |
| Rucaparib Maintenance Therapy in Advanced Cervical Cancer (NCT03795272) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2019-10-01 |
| Trial in Patients With Relapsed Ovarian Cancer (NCT03267589) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2018-05-14 |
| Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer (NCT02730429) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2017-02-15 |
| Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer (NCT02730416) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2016-12-12 |
| Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (NCT02354131) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2015-02-15 |
| A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer (NCT02026921) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2004-06-01 |
| Exemestane in Advanced and Recurrent Endometrial Carcinoma (NCT01965080) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2004-03-01 |
| Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane (NCT02728622) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2002-03-01 |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer (NCT00005583) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2000-01-01 |
| Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (NCT00004934) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 1999-08-01 |